Trillium Therapeutics Inc (TRIL)

[vinmantoo]

With the likelihood of PRs turning to CRs with the added assessment time, this historical "cult" stock could become much more than speculative. It could have the most solid science of the CD47 space.

FTSV already proved that anti-CD47 was a viable anti-cancer approach and that is when I dramatically increased my shares of TRIL at prices from $0.45 through $2. The early TRIL data suggest TTI-621 and TTI-622 will be at least as good but likely superior. For me now I am deciding when to sell a bit to get back some if not all my investment so that I am playing with house money. I came close to doing that yesterday. Depending on how the stock goes as ASH draws closer, I may do it before ASH. I learned the hard way that it is better to make less than I could have than to lose more than I am comfortable with. Besides, if there is a nice run up, often there is a drop after as the old sell the news kicks in. That could provide a buying opportunity with the cash I accumulated by the pre-ASH selling.

You also have to consider that TRIL might issue another offering if the price rises again after ASH, say to generate another $100 million+. Can't have too much money on hand. We will see.